Overview

Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
With this study, the investigators will like to determine if taking a dose of the study medication, called Polypodium leucotomos (PL), prevents some of the changes in the skin caused by the adverse effects of UVA, a type of ultraviolet light.
Phase:
Phase 2
Details
Lead Sponsor:
University of Miami